نتایج جستجو برای: kit 6

تعداد نتایج: 980452  

Journal: :iranian journal of nuclear medicine 2008
mostafa gandomkar reza najafi mohammad mazidi mostafa goudarzi seyed hassan mirfallah

introduction: ubiquicidin 29-41 (ubi) is a fragment of the cationic antimicrobial peptide that is present in various species including humans. the purpose of this study was to investigate radiochemical and biological characteristics of [6-hydrazinopyridine-3-carboxylic acid (hynic)]-ubi 29-41 designed for the labeling with 99mtc using tricine as coligand. methods: synthesis was preformed on a ...

Journal: :Chemical communications 2010
Feng Jiao Heinz Frei

Nanostructured Mn oxide clusters supported on mesoporous silica KIT-6 efficiently evolve O(2) in aqueous solution under mild conditions.

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Karen A Chernoff Lindsey Bordone Basil Horst Katherine Simon William Twadell Keagan Lee Jason A Cohen Shuang Wang David N Silvers Georg Brunner Julide Tok Celebi

PURPOSE Gain-of-function mutations in BRAF, NRAS, or KIT are associated with distinct melanoma subtypes with KIT mutations and/or copy number changes frequently observed among melanomas arising from sun-protected sites, such as acral skin (palms, soles, and nail bed) and mucous membranes. GAB2 has recently been implicated in melanoma pathogenesis, and increased copy numbers are found in a subse...

2012
V. Corbo S. Beghelli S. Bersani D. Antonello G. Talamini M. Brunelli P. Capelli M. Falconi A. Scarpa

BACKGROUND Kinases represent potential therapeutic targets in pancreatic endocrine tumours (PETs). PATIENTS AND METHODS Thirty-five kinase genes were sequenced in 36 primary PETs and three PET cell lines: (i) 4 receptor tyrosine kinases (RTK), epithelial growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), tyrosine-protein kinase KIT (KIT), platelet-derived growth f...

Journal: :Blood 1995
K Ogawa Y Takeda M Tashima H Sawai T Toi T Okazaki H Sawada Y Maruyama M Okuma

We previously reported that the K562 cell line K562YO expressed a high level of the c-kit gene. In this study, we analyzed the mechanism of this expression and investigated the effects of the serine/threonine kinases such as protein kinase C (PKC) and cyclic adenosine 3',5'-monophosphate (cAMP)-dependent kinase (PKA) on it. The half-life of the c-kit mRNA in K562YO cells was greater than 10 hou...

Journal: :Carcinogenesis 2006
Nikola Holtkamp Ali Fuat Okuducu Jana Mucha Anastasia Afanasieva Christian Hartmann Isis Atallah Lope Estevez-Schwarz Christian Mawrin Reinhard E Friedrich Victor-F Mautner Andreas von Deimling

Platelet-derived growth factor receptor alpha (PDGFRalpha) and c-Kit are receptor tyrosine kinases. Both are targets of the tyrosine kinase inhibitor imatinib mesylate which is approved for treatment of some cancers. In order to assess the role of PDGFRalpha and c-Kit in malignant peripheral nerve sheath tumours (MPNST) we examined human tumours for structural alterations, protein and ligand ex...

2017
Lugao Tian Beibei Zhu Shi Liu

Background. Electroacupuncture (EA) at ST36 has been used to regulate gastric motility and effectively improve gastric emptying in diabetic patients. Nevertheless, the specific mechanisms underlying the efficacy of this treatment remain unknown. The aim of this study was to assess the variations of interstitial cells of Cajal (ICC) and explore the changes in mSCF/KIT-ETV1 signaling in the antru...

Journal: :Blood 2004
Petri Bono Andreas Krause Margaret von Mehren Michael C Heinrich Charles D Blanke Sasa Dimitrijevic George D Demetri Heikki Joensuu

Imatinib mesylate is a selective inhibitor of a few tyrosine kinases including KIT, and it is the first effective treatment for gastrointestinal stromal tumors (GISTs). We monitored the serum levels of KIT, KIT ligand (stem cell factor, SCF), and the vascular endothelial growth factor (VEGF) in patients with advanced GISTs treated with imatinib in a prospective randomized trial. Patients with G...

2016
Do-Kyun Kim Michael A. Beaven Joseph M. Kulinski Avanti Desai Geethani Bandara Yun Bai Calman Prussin Lawrence B. Schwartz Hirsh Komarow Dean D. Metcalfe Ana Olivera

Neoplastic accumulation of mast cells in systemic mastocytosis (SM) associates with activating mutations in the receptor tyrosine kinase KIT. Constitutive activation of tyrosine kinase oncogenes has been linked to imbalances in oxidant/antioxidant mechanisms in other myeloproliferative disorders. However, the impact of KIT mutations on the redox status in SM and the potential therapeutic implic...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید